Singapore
Business leader with end-to-end ownership across revenue generation, operations, and supply chain within the healthcare sector. Proven track record in securing institutional contracts, improving cost efficiency, and strengthening working capital performance. Focused on financial discipline, execution control, and building scalable, sustainable growth.
Secured and managed long-term institutional contracts generating consistent revenue across public healthcare, research institutions, and retail pharmacies End-to-end ownership across revenue generation, operations, and supply chain within the healthcare sector
Fabricated and characterized of liposomes for drug encapsulation Investigated the use of thiol based lipids to achieve s-nitrosylation